SCHEDULES

SCHEDULE 2 U.K. Amendment of the Human Medicines (Amendment etc.) (EU Exit) Regulations 2019

PART 4 U.K. Amendment of Part 5 (amendment of Part 5 (marketing authorisations))

71.  In regulation 94 (amendment of regulation 97 (breach of pharmacovigilance condition)), omit paragraph (2). U.K.

Commencement Information

I1 Sch. 2 para. 71 in force at 31.12.2020 immediately before IP completion day, see reg. 1